Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent <i>In vivo</i> Activity in MesotheliomaAndrea Sartore‐Bianchi, Luciano Mutti|Clinical Cancer Research|2007Cited by 93